{
  "pmcid": "11424262",
  "sha256": "25f348fe386d8ee5191f9ae087973e859b23ec9a035075db62e7179100d119a0",
  "timestamp_utc": "2025-11-09T15:19:18.282096+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 12.624542807221903,
    "reading_ease": 36.2965928945836,
    "word_count": 303
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Eligible adult trauma patients admitted to the intermediate or intensive care unit were randomized"
      },
      "Participants": {
        "score": 2,
        "evidence": "Eligible adult trauma patients admitted to the intermediate or intensive care unit"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized upon admission to our institutional MMPR per usual care (UC) or UC plus sub-dissociative KI"
      },
      "Objective": {
        "score": 1,
        "evidence": "We hypothesized that the addition of a sub-dissociative ketamine infusion (KI) to a standardized oral MMPR reduces inpatient opioid exposure."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was morphine milligram equivalents per day (MME/d)"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "A total of 300 patients were included in the final analysis with 144 randomized to KI and 156 to UC."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A total of 300 patients were included in the final analysis"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Patients receiving KI had an absolute reduction of 7 MME/day, 96 total MME, and 5% in OP%. Additionally, KI had a relative risk (RR) reduction of 19% in MME/day (RR 0.81 [0.69 â€“ 0.95], pp = 99%)"
      },
      "Harms": {
        "score": 1,
        "evidence": "The KI group had a higher rate of delirium (11% versus 6%)"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}